Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1989
Pharmacokinetics of perindopril: therapeutic consequences
K R Lees, D M Hughes, C A McNeill, et al.
British Journal of Clinical Pharmacology
|
July 1, 1990
Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man
N J MacDonald, D M Hughes, K R Lees, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha 1-adrenoceptor responsiveness of trimazosin in man
J Vincent, H L Elliott, P A Meredith, et al.
Clinical Pharmacology and Therapeutics
|
February 1, 1984
Trimazosin in normotensive subjects
H L Elliott, J Vincent, D M Hughes, et al.
British Journal of Clinical Pharmacology
|
July 1, 1988
Ketanserin concentration-effect relationships in individual hypertensive patients
R Donnelly, H L Elliott, P A Meredith, et al.
Child Abuse & Neglect
|
October 30, 1998
Abuse characteristics among childhood sexual abuse survivors in therapy: a gender comparison
S N Gold, J D Elhai, B A Lucenko, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1993
A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilat
J R Wade, D M Hughes, A W Kelman, et al.
Clinical and Experimental Dermatology
|
February 17, 2018
Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair<sup>®</sup> )
J D M Hughes, T Olynyc, H Chapdelaine, et al.
Journal of Animal Science
|
September 26, 1997
Raw and rendered animal by-products as ingredients in dog diets
S M Murray, A R Patil, G C Fahey, et al.
The Journal of Nutrition
|
December 30, 1998
Raw and rendered animal by-products as ingredients in dog diets
S M Murray, A R Patil, G C Fahey, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1989
Pharmacokinetics of perindopril: therapeutic consequences
K R Lees, D M Hughes, C A McNeill, et al.
British Journal of Clinical Pharmacology
|
July 1, 1990
Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man
N J MacDonald, D M Hughes, K R Lees, et al.
European Journal of Clinical Pharmacology
|
January 1, 1985
The effect of cimetidine on the pharmacokinetics, pharmacodynamics and alpha 1-adrenoceptor responsiveness of trimazosin in man
J Vincent, H L Elliott, P A Meredith, et al.
Clinical Pharmacology and Therapeutics
|
February 1, 1984
Trimazosin in normotensive subjects
H L Elliott, J Vincent, D M Hughes, et al.
British Journal of Clinical Pharmacology
|
July 1, 1988
Ketanserin concentration-effect relationships in individual hypertensive patients
R Donnelly, H L Elliott, P A Meredith, et al.
Child Abuse & Neglect
|
October 30, 1998
Abuse characteristics among childhood sexual abuse survivors in therapy: a gender comparison
S N Gold, J D Elhai, B A Lucenko, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1993
A novel statistical approach for the comparison of analytical methods to measure angiotensin converting enzyme activity, enalaprilat, and benazeprilat
J R Wade, D M Hughes, A W Kelman, et al.
Clinical and Experimental Dermatology
|
February 17, 2018
Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair<sup>®</sup> )
J D M Hughes, T Olynyc, H Chapdelaine, et al.
Journal of Animal Science
|
September 26, 1997
Raw and rendered animal by-products as ingredients in dog diets
S M Murray, A R Patil, G C Fahey, et al.
The Journal of Nutrition
|
December 30, 1998
Raw and rendered animal by-products as ingredients in dog diets
S M Murray, A R Patil, G C Fahey, et al.
Page
of 6